Evidence map›Paper›PMID 40986229›Full record

ArticleForensic science, medicine, and pathology2025

Postmortem interval estimation based on protein analysis and marker studies in different organs in vivo.

Abdullah M K Albloshi, Mohamed F El-Refaei, Eman A A Abdallah

Abstract read
PubMed Publisher
In one paragraph

Article in Forensic science, medicine, and pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abdullah M K AlbloshiFaculty of Medicine, Al-Baha University, Al-Baha, Kingdom of Saudi Arabia.
Mohamed F El-RefaeiFaculty of Medicine, Al-Baha University, Al-Baha, Kingdom of Saudi Arabia. melrefaei2000@yahoo.com.ORCID http://orcid.org/0000-0002-2423-9353
Eman A A AbdallahFaculty of Medicine, Al-Baha University, Al-Baha, Kingdom of Saudi Arabia.ORCID http://orcid.org/0000-0001-5349-1278

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Estimating the postmortem interval (PMI) is a crucial aspect of forensic death-related investigations. However, determining the time of death remains one of the biggest challenges in forensic medicine. This study aims to assess the potential of protein analysis as a vital tool and histopathological examination to evaluate the PMI. Fifty male rats were randomly distributed into five groups of 10. These rats were kept at room temperature (22 °C) with a relative humidity of 15% during the period between the time of death and organ removal. The kidneys and Livers were extracted at 0-, 24-, 48-, 72-, and 96-hour intervals. The β-catenin immunohistochemical analysis showed no immunoreactivity in either organ at 0 h, which increased to severe immunoreactivity at 96 h after death. Additionally, flow cytometry demonstrated a decline in liver and kidney Bcl-2 expression at 96 h, at 17.5% and 12.8%, respectively, as the postmortem period increased. Moreover, a histopathological examination of the Liver and kidney showed progressively greater degradation over time as the PMI increased, resulting in the loss of normal Liver and kidney architecture at 96 h. These findings suggest the potential use of specific proteins' autolytic alterations as definite diagnostic parameters for the PMI. Autolytic processes have a delayed onset and show a significant increase in progression rate at each time interval. Different organs suffer different rates of autolysis in correlation to their structure and enzymatic content. Further studies are required to evaluate the definite roles of β-catenin and Bcl-2 expression as predictive tools for future applications in humans based on extensive experimental studies.

Indexed as

beta CateninKidneyLiverPostmortem ChangesAnimalsAutolysisBiomarkersFlow CytometryForensic PathologyImmunohistochemistryMaleModels, AnimalProto-Oncogene Proteins c-bcl-2RatsRats, Sprague-DawleyBcl2 protein, ratbeta CateninBiomarkersProto-Oncogene Proteins c-bcl-2Bcl-2Flow cytometryPostmortem intervalΒ-catenin

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.